
Biotech firm Zealand Pharma has announced a directed issuance of 2.89 million new shares and a private placement, corresponding to a total 6.6% of the firm’s share capital.
The price per share is DKK 95 (USD 13.6), and the firm expects gross proceeds to amount to DKK 275m (USD 39.4m), according to a notification released on Wednesday after trading closed.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app